SLC22A17

Across TCGA cell cohorts, SLC22A17 RNA expression is significantly associated with the go_rna of many other GO terms, with 4,274 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible SLC22A17-associated GO terms across cancer lineages are Regulation of myoblast fusion, Regulation of syncytium formation by plasma membrane fusion, and Negative regulation of myoblast fusion. Each is linked with SLC22A17 in more than 16 cancer types. Because this analysis shows association rather than direction, both SLC22A17-to-partner and partner-to-SLC22A17 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Regulation of myoblast fusion grouped by SLC22A17-low versus SLC22A17-high in OESOPHAGUS.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (SLC22A17→partner) and Y-score (partner→SLC22A17) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
OESOPHAGUS	Regulation of myoblast fusion →	+0.117	+2.181	<.001	<.001	3	17
OESOPHAGUS	Regulation of syncytium formation by plasma membrane fusion →	+0.168	+3.082	<.001	<.001	3	17
OESOPHAGUS	Negative regulation of myoblast fusion →	+0.137	+2.316	<.001	<.001	3	16
OESOPHAGUS	Negative regulation of syncytium formation by plasma membrane fusion →	+0.137	+2.316	<.001	<.001	3	16
BONE	Protein-DNA complex assembly →	+0.059	+1.355	.005	.002	3	16
BONE	Protein-DNA complex organization →	+0.066	+1.345	.002	.002	3	15

Each partner links to its Q-omics profile. Showing the 6 strongest of 4,274 associations by consensus.

Regulation of myoblast fusion by SLC22A17 expression — OESOPHAGUS

Explore this box plot interactively →